Azienda Ospedaliera San Giovanni Addolorata   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Rome Italy (1338)

Organization Overview

First Clinical Trial
2019
NCT04102852
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

San Giovanni Addolorata Hospital | S.Giovanni Addolorata Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

palmitoylethanolamide (1 trial)

Drugs in Phase 2 Trials (1)

lactobacillus rhamnosus (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2